Meijer is making two of the most sought-after GLP-1 medications, Wegovy and Ozempic, more affordable for its customers by accepting savings programs available with the patient support program NovoCare.
Through this program, the retailer's pharmacy locations are offering these medications at significantly reduced out-of-pocket prices, according to the company. Patients who haven't previously used a coupon for the medications can get the two lowest‑dose Wegovy or Ozempic injection pens for $199 per month for their first two months; prescriptions must be filled before March 31. After the introductory period, most doses will be available for $349 per month, while the highest Ozempic dose will remain at $499 per month.
Meijer also announced the availability of the newly FDA-approved oral Wegovy pill, offering customers an alternative to injectable GLP-1 therapy. Eligible patients can access special pricing through the NovoCare program, including out-of-pocket options starting at $149 per month and insurance co-pays as low as $25, Meijer officials said.
Customers can visit their local Meijer pharmacy and present a coupon from NovoCare when filling their prescription. No insurance is required. Meijer also offers virtual consultations with its registered dietitians and personalized programs for GLP-1 users.
In 2024, Costco began offering its shopping members access to popular GLP-1 weight-loss drugs through that retailer's partnership with the online health care service provider Sesame. At that time, the service was available to all members for an initial three-month subscription rate of $179.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.